The Business Research Company’s NGS-Based RNA-Sequencing Market Research Reveals Path To $12.73 Billion By 2030
LONDON, GREATER LONDON, UNITED KINGDOM, August 19, 2026 /EINPresswire.com/ — “The NGS-based RNA-sequencing market has witnessed remarkable growth recently, driven by advancements in genomic research and sequencing technologies. As the demand for precise molecular analysis rises across various sectors, this market is set to experience significant expansion in the coming years. Let’s explore the market’s size, key drivers, leading regions, and future trends shaping its trajectory.
Rapid Increase in NGS-Based RNA-Sequencing Market Size
The market for NGS-based RNA-sequencing has grown substantially and is anticipated to increase from $4.2 billion in 2025 to $5.27 billion in 2026, reflecting a strong compound annual growth rate (CAGR) of 25.3%. This surge in recent years has been fueled by the broadening scope of genomic research projects, the decreasing costs of sequencing technology, expanded use of RNA sequencing in academic environments, availability of sophisticated sequencing platforms, and enhancements in bioinformatics tools.
Download a free sample of the ngs-based rna-sequencing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Long-Term Growth Outlook for NGS-Based RNA-Sequencing
Looking ahead, the market is projected to soar to $12.73 billion by 2030, maintaining an impressive CAGR of 24.7%. This anticipated growth stems from wider clinical adoption of RNA-sequencing methods, growing investments in precision medicine, increasing pharmaceutical research activities, a rising need for integrated data analysis solutions, and a heightened focus on multi-omics studies. Key trends expected to define this period include the rise of high-throughput RNA sequencing technologies, greater demand for single-cell RNA sequencing, expanding use of cloud-based bioinformatics platforms, deeper integration of transcriptomics into personalized medicine, and a stronger emphasis on data accuracy and scalability.
Understanding NGS-Based RNA-Sequencing and Its Capabilities
NGS-based RNA-sequencing refers to a technique that identifies and quantifies RNA molecules present in a biological sample at a specific time, utilizing next-generation sequencing technology. This cutting-edge method is capable of massively parallel sequencing, offering exceptional throughput, scalability, and speed. It enables detailed determination of nucleotide sequences across entire genomes or targeted segments of DNA or RNA, making it a powerful tool for genetic and molecular analysis.
View the full ngs-based rna-sequencing market report:
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Pharmaceutical Industry as a Major Growth Driver for NGS-Based RNA-Sequencing
One of the most significant forces propelling the NGS-based RNA-sequencing market forward is the expanding pharmaceutical sector. This industry, which encompasses drug discovery, development, and production by both public and private organizations, relies heavily on RNA-sequencing to analyze gene expression comprehensively. Such insights help identify drug targets, evaluate drug efficacy, and unravel disease mechanisms, thereby streamlining the drug development pipeline through a deeper molecular understanding.
Supporting evidence of this trend can be seen in data from the Centers for Medicare & Medicaid Services (CMS), a US federal agency, which reported that prescription drug spending increased by 11.4% in 2023, reaching $449.7 billion—up from 7.8% growth in 2022. This growth in pharmaceutical expenditure indicates a rising demand for advanced molecular tools like NGS-based RNA-sequencing, reinforcing its market expansion.
Regional Leaders and Growth Prospects in the NGS-Based RNA-Sequencing Market
In terms of regional performance, North America held the largest share of the NGS-based RNA-sequencing market in 2025. Meanwhile, the Asia-Pacific region is expected to exhibit the fastest growth rate throughout the forecast period. The comprehensive market analysis considers various regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, presenting a global perspective on market developments.
Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
